Induction of labor in twin pregnancy after 36 weeks does not increase maternal-fetal morbidity

International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
T HarleJ J Leng

Abstract

To compare maternal and perinatal outcomes in twin pregnancy patients without any fetal or maternal disease, managed by labor induction or expectant management after 36 weeks gestation. We conducted a case-control study of 81 patients: labor induction (n=36) vs. expectant management (n=45). Labor was induced using oxytocin (n=18), vaginal prostaglandins (n=6) or intrauterine balloon catheter (n=12) according to the Bishop score. Maternal and perinatal outcome variables were compared among both groups. The characteristics of the labor induction group and the expectant management group were not statistically different, except for the rate of nulliparae (55.6% vs. 33.3%) and the rate of epidural analgesia (100% vs. 80%). There was no significant difference in labor time (6.5+/-2.8 h vs. 6.0+/-3.6 h), cesarean section rate (8.3% vs. 13.3%) or duration of maternal hospitalization (7.3+/-2.0 days vs. 7.5+/-2.3 days) in the labor induction group and in the expectant management group, respectively. The birth weight was higher in the labor induction group than in the expectant management group (2639+/-352 g vs. 2463+/-298 g, P<0.001). The rate of Apgar score <7 at 5 min was 0% and 3.3%, respectively. Neonatal intensive care unit admissi...Continue Reading

References

Jan 15, 1991·American Journal of Epidemiology·J C KleinmanS S Kessel
Sep 15, 1995·La Revue du praticien·P Boulot, P L Giacalone
Sep 1, 1993·American Journal of Obstetrics and Gynecology·B LukeT R Johnson
Sep 1, 1995·Baillière's Clinical Obstetrics and Gynaecology·J O GardosiT Mul
Jun 1, 1997·American Journal of Obstetrics and Gynecology·S A FriedmanB M Sibai
Aug 1, 1997·Obstetrics and Gynecology·M B FausettA J Satin
Mar 21, 1998·Clinical Obstetrics and Gynecology·J L Kiely
Mar 21, 1998·Clinical Obstetrics and Gynecology·E PapiernikA Cervantes
Mar 21, 1998·Clinical Obstetrics and Gynecology·G R AlexanderE Papiernik
Jun 3, 1999·Gynecologic and Obstetric Investigation·M ManorZ Hagay
Nov 16, 1999·American Journal of Obstetrics and Gynecology·S T ChasenF A Chervenak
Jan 12, 2000·Gynecologic and Obstetric Investigation·S SuzukiT Araki
Aug 19, 2000·Clinical Obstetrics and Gynecology·F R Witter

❮ Previous
Next ❯

Citations

Jun 1, 2005·Clinics in Perinatology·Andrew J Healy, Sreedhar Gaddipati
Mar 20, 2014·BJOG : an International Journal of Obstetrics and Gynaecology·T GanchimegUNKNOWN WHO Multicountry Survey on Maternal and Newborn Health Research Network
Jul 9, 2014·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Georgine HuberBirgit Seelbach-Göbel
Jun 17, 2015·BMC Pregnancy and Childbirth·Maria Jonsson
Dec 8, 2016·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Mariana Vide TavaresPaulo Moura
Mar 17, 2004·Clinical Obstetrics and Gynecology·Christopher Robinson, Suneet P Chauhan
Apr 19, 2007·Gynäkologisch-geburtshilfliche Rundschau·Gottfried HasenöhrlHorst Steiner
Jan 8, 2017·BMC Pregnancy and Childbirth·Elad Mei-DanJon F R Barrett
Feb 24, 2006·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Melissa C BushCarl J Saphier

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.